Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Characterization of glucose-insulin responsiveness and impact of fetal number and sex difference on insulin response in the sheep fetus
FOXO4-DRI has three main pharmacogenetic advantages: its stability (resistance to degradation by cellular proteases), half-life (compared to L-peptide equivalents, it's longer), and cell-penetrating properties (cell-penetrating sequences improve intracellular delivery)
Patience here costs you 15 extra seconds and saves you the full potency of your vial
But large-scale human clinical trials are still needed
US$ 28.20
US$ 24.06
US$ 20.00
